Covered recipient · General Payments record
LISA GONZALEZ
Physician Assistants & Advanced Practice Nursing Providers Nurse Practitioner Adult Health
General Payments · PY2021–2024
$2,436.69
- Reported across 26 records
- CMS publication 2026-01-23
Financial relationships do not necessarily indicate an improper relationship; the data is open to interpretation.
How these totals are calculated
- The total is the sum of the General Payments records CMS published for the labeled program year(s), exactly as published. Nothing is estimated, weighted, or combined across categories.
- General Payments only. Research and Ownership/Investment are separate datasets and are never summed with these figures; amounts are kept separate per program year.
- Featured-page threshold (a presentation gate, not a judgment): records>=3 OR total>=100 (all years).
- Methodology & Data — sourcing, labeling, and limitations.
By nature of payment
PY2024 · sorted by reported total
| Nature of payment | Amount | Records |
|---|---|---|
| Food and Beverage | $768.36 | 8 |
By paying entity
PY2024 · sorted by reported total
| Paying entity | Amount | Records |
|---|---|---|
| Bayer HealthCare Pharmaceuticals Inc. | $125.51 | 1 |
| Actelion Pharmaceuticals US, Inc. | $123.71 | 1 |
| Abbott Laboratories | $112.42 | 1 |
| Acerta Pharma LLC | $100.80 | 1 |
| Corcept Therapeutics | $100.80 | 1 |
| Silk Road Medical, Inc. | $94.50 | 1 |
| Amgen Inc. | $94.31 | 1 |
| Currax Pharmaceuticals LLC | $16.31 | 1 |
By program year
All program years on this page · sorted by year
Payment records · PY2024 (8)
Sorted by paying entity, then date · as published by CMS
| Paying entity | Amount | Date | Nature of payment | Dispute status | Published | Record ID | Source |
|---|---|---|---|---|---|---|---|
| Abbott Laboratories | $112.42 | 12/03/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1124983438 | CMS |
| Actelion Pharmaceuticals US, Inc. | $123.71 | 03/27/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1078877968 | CMS |
| Amgen Inc. | $94.31 | 05/16/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1117263069 | CMS |
| AstraZeneca Pharmaceuticals LP | $100.80 | 03/14/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1105709480 | CMS |
| Bayer Healthcare Pharmaceuticals Inc. | $125.51 | 08/30/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1086281024 | CMS |
| Corcept Therapeutics | $100.80 | 05/23/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1117746475 | CMS |
| Currax Pharmaceuticals LLC | $16.31 | 05/07/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1089523493 | CMS |
| Silk Road Medical, Inc. | $94.50 | 03/05/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1082260286 | CMS |
Source & provenance
- Dataset
- CMS Open Payments — General Payments
- Publisher of source data
- Centers for Medicare & Medicaid Services
- CMS publication date
- 2026-01-23
- Program years on this page
- 2021, 2022, 2023, 2024
- Generated from
- OP_DTL_GNRL_PGYR2024_P01232026_01102026.csv
One page per canonical provider; split Profile_IDs are merged via Associated_Covered_Recipient_Profile_ID_1/_2 from the Covered Recipient Profile Supplement.
Corrections to the substance of a record route to CMS through its review-and-dispute process; errors in how this site mirrors or displays a record route to us. Both paths are described in Methodology & Data.